News & Updates

Show Multimedia Only

How useful is anti-DFS70 in identifying ANA-positive patients without SARD?

18 May 2022 by

A Singapore study has found an association between the presence of anti-DFS70 and a false-positive antinuclear antibody (ANA) test in 8.6 percent of its patients. Moreover, anti-DFS70 shows no association with the absence of systemic autoimmune rheumatic disease (SARD).

How useful is anti-DFS70 in identifying ANA-positive patients without SARD?

18 May 2022

Omega-3 supplements help reduce falls in older adults

18 May 2022

Supplementation with omega-3 fatty acids extends a modest benefit on the incidence of total falls among generally healthy, active, and vitamin D-replete older adults, while a daily high dose of vitamin D or a simple home exercise program (SHEP) offers no benefits.

Omega-3 supplements help reduce falls in older adults

18 May 2022

Wearables boost eating disorder program completion, app engagement

18 May 2022 by

Using wearable devices helps improve study completion among people with eating disorders, as well as boosts their engagement with a smartphone app intervention, according to a recent study. Greater program retention, in turn, may lead to better outcomes.

Wearables boost eating disorder program completion, app engagement

18 May 2022

Physical activity beneficial to NAFLD patients

18 May 2022

For nonalcoholic fatty liver disease (NAFLD) patients, performing physical activity appears to confer some protection against the development of fibrosis, sarcopenia, and cardiovascular disease (CVD), according to a study.

Physical activity beneficial to NAFLD patients

18 May 2022

B infantis EVC001 cuts necrotizing enterocolitis, mortality in VLBW infants

18 May 2022

Probiotics with the EVC001 strain of the Bifidobacterium longum subspecies infantis, as a supplement to human milk, appears to significantly reduce the risk of necrotizing enterocolitis (NEC) and associated deaths in very low birth weight (VLBW) infants, a recent study has found.

B infantis EVC001 cuts necrotizing enterocolitis, mortality in VLBW infants

18 May 2022

SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes

18 May 2022

Treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) leads to lower rates of cardiovascular disease (CVD) events in patients with type 2 diabetes mellitus (T2DM) than does dipeptidyl peptidase-4 inhibitors (DPP4i), reports a recent Japan study.

SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes

18 May 2022

High BMI might promote MGUS progression to multiple myeloma

17 May 2022

In individuals with monoclonal gammopathy of undetermined significance (MGUS), obesity or high body mass index (BMI) seems to aggravate the risk of disease progression to multiple myeloma (MM), an effect that appears to be stronger in women, a recent study has found.

High BMI might promote MGUS progression to multiple myeloma

17 May 2022

Polygenic risk scores for hepatic fat, NAFLD pinpoint Asians at risk of HCC

17 May 2022 by

Both the polygenic risk score (PRS) for hepatic fat (HFC-PRS) derived from non-Asians and the novel PRS for nonalcoholic fatty liver disease (NAFLD) derived from East Asians can predict the incidence of hepatocellular carcinoma (HCC) in Singaporeans, as shown in a study.

Polygenic risk scores for hepatic fat, NAFLD pinpoint Asians at risk of HCC

17 May 2022

Does targeted hypothermia improve outcomes in cardiac arrest survivors?

17 May 2022

Targeted temperature management, compared with normothermia, does not appear to result in improved survival or neurological outcomes in comatose patients following cardiac arrest, claims a recent study.

Does targeted hypothermia improve outcomes in cardiac arrest survivors?

17 May 2022

Relugolix combo improves uterine fibroid symptoms regardless of fibroid location

17 May 2022 by

Combination therapy with relugolix (once daily relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) leads to improvement in heavy menstrual bleeding (HMB) and in other uterine fibroid (UF)-related symptoms independent of the location of the largest fibroid, results of a recent study have shown.

Relugolix combo improves uterine fibroid symptoms regardless of fibroid location

17 May 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

How useful is anti-DFS70 in identifying ANA-positive patients without SARD?

How useful is anti-DFS70 in identifying ANA-positive patients without SARD?

Omega-3 supplements help reduce falls in older adults

Omega-3 supplements help reduce falls in older adults

Wearables boost eating disorder program completion, app engagement

Wearables boost eating disorder program completion, app engagement

Physical activity beneficial to NAFLD patients

Physical activity beneficial to NAFLD patients

B infantis EVC001 cuts necrotizing enterocolitis, mortality in VLBW infants

B infantis EVC001 cuts necrotizing enterocolitis, mortality in VLBW infants

SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes

SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes

High BMI might promote MGUS progression to multiple myeloma

High BMI might promote MGUS progression to multiple myeloma

Polygenic risk scores for hepatic fat, NAFLD pinpoint Asians at risk of HCC

Polygenic risk scores for hepatic fat, NAFLD pinpoint Asians at risk of HCC

Does targeted hypothermia improve outcomes in cardiac arrest survivors?

Does targeted hypothermia improve outcomes in cardiac arrest survivors?

Relugolix combo improves uterine fibroid symptoms regardless of fibroid location

Relugolix combo improves uterine fibroid symptoms regardless of fibroid location